MENU
ACRV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acrivon Therapeutics (ACRV) Earnings Date & Reports

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

A.I. Advisor
published Earnings

ACRV is expected to report earnings to rise 110.91% to -115 cents per share on November 06

Acrivon Therapeutics ACRV Stock Earnings Reports
Q3'25
Est.
$-1.16
Q2'25
Beat
by $0.54
Q1'25
Beat
by $0.50
Q4'24
Beat
by $0.17
Q3'24
Beat
by $0.15
The last earnings report on August 13 showed earnings per share of -55 cents, beating the estimate of -109 cents. With 97.77K shares outstanding, the current market capitalization sits at 42.15M.
View a ticker or compare two or three
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACRV showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com